Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...
Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...
Jupiter Endovascular, Inc. announced that its Vertex catheter has received FDA 510(k) clearance for the insertion of endovasc ...
Vertex Pharmaceuticals (VRTX) announced that the FDA has granted breakthrough therapy designation to povetacicept for the treatment of IgAN. Pove ...
Zacks Investment Research on MSN
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...
Abstract: In this article, we develop distributed computation algorithms for Nash equilibriums of linear–quadratic network games with proven differential privacy guarantees. In a network game with ...
Abstract: Multi-label propagation algorithms (MLPAs) aim to find vertex communities in a complex network or a cloud system by propagating and updating vertex labels, which have been widely applied in ...
The various types of special functions have become essential tools for scientists and engineers. One of the important classes of special functions is of the hypergeometric type. It includes all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback